Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Immunoglobulin G (IgG) mediates pro- and anti-inflammatory activities through the engagement of its Fc fragment (Fc) with distinct Fcg receptors (FcgRs). One class of Fc-FcgR interactions generates pro-inflammatory effects of immune complexes and cytotoxic antibodies. In contrast, therapeutic intravenous gamma globulin and its Fc fragments are anti-inflammatory. We show here that these distinct properties of the IgG Fc result from differential sialylation of the Fc core polysaccharide. IgG acquires anti-inflammatory properties upon Fc sialylation, which is reduced upon the induction of an antigen-specific immune response. This differential sialylation may provide a switch from innate anti-inflammatory activity in the steady state to generating adaptive pro-inflammatory effects upon antigenic challenge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CREB activation can promote the expression of anti-inflammatory genes while inhibiting inflammatory genes.294,295”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [295]
Citations
Cites
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
Imbach, P., d'APUZZO, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schöni, M., & Wagner, H. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92400-4 · Cited by 1,666
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Self-citationDivergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
Self-citationArthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
Nimmerjahn, F., Bruhns, P., Horiuchi, K., & Ravetch, J. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.010 · Cited by 660
Self-citationManipulating the Immune System with Immune Globulin
Oates, J. A., Wood, A. J. J., & Dwyer, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260206 · Cited by 648
Effect of glycosylation on antibody function: implications for genetic engineering
Wright, A., & Morrison, S. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 312
Research works printed but not linked: 1
- M. Holland et al., Biochim. Biophys. Acta1760, 669 (2005).
Cited by
Items 901–1,000 of 1,003
Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris
Wang, S., Rong, Y., Wang, Y., Kong, D., Wang, P. G., Chen, M., & Kong, Y. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-1280-0 · Cited by 22
Victor, J. R. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12335 · Cited by 22
Variability of serum IgG sialylation and galactosylation degree in women with advanced endometriosis
Sołkiewicz, K., Krotkiewski, H., Jędryka, M., & Kratz, E. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-85200-x · Cited by 21
Chapter 1 Immune Regulation by B Cells and Antibodies
Hoehlig, K., Lampropoulou, V., Roch, T., Neves, P., Calderón‐Gómez, E., Anderton, S. M., Steinhoff, U., & Fillatreau, S. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00401-x · Cited by 34
B cells in cardiac transplants: From clinical questions to experimental models
Baldwin, W. M., Halushka, M. K., Valujskikh, A., & Fairchild, R. L. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.08.017 · Cited by 22
Luo, J., Yu, L., Guo, Y., & Li, M. (2011) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2011.11.008 · Cited by 22
Measuring decreased serum IgG sialylation: a novel clinical biomarker of lupus
Chen, X.-X., Chen, Y.-Q., & Ye, S. (2015) · Lupus · doi:10.1177/0961203315570686 · Cited by 23
Inhibition of TNF-α reduces transplant arteriosclerosis in a murine aortic transplant model
Wollin, M., Abele, S., Bruns, H., Weyand, M., Kalden, J. R., Ensminger, S. M., & Spriewald, B. M. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00802.x · Cited by 21
Therapeutic cleavage of IgG: new avenues for treating inflammation
Nandakumar, K. S., & Holmdahl, R. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.01.007 · Cited by 22
Tayi, V. S., & Butler, M. (2015) · Journal of Biological Methods · doi:10.14440/jbm.2015.52 · Cited by 22
The therapeutic potential of sialylated Fc domains of human IgG
Pleass, R. J. (2021) · mAbs · doi:10.1080/19420862.2021.1953220 · Cited by 25
Meng, X., Song, M., Vilaj, M. Ć., Štambuk, J., Mamatyusupu, D., Zhang, J., Liu, D., Wang, H., Zhang, X., Zhang, J., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070614 · Cited by 26
Immune complexes as culprits of immunopathology in severe COVID-19
Kolb, P., Giese, S., Voll, R. E., Hengel, H., & Falcone, V. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00743-8 · Cited by 23
Emerging Methods in Biosensing of Immunoglobin G—A Review
Azam, T., Bukhari, S. H., Liaqat, U., & Miran, W. (2023) · Sensors · doi:10.3390/s23020676 · Cited by 27
Hou, Y., Chang, S., Chen, S., & Zhang, W. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109782 · Cited by 25
Kajii, M., Kobayashi, F., Kashihara, J., Yuuki, T., Kubo, Y., Nakae, T., Kamizono, A., Kuzumoto, Y., & Kusunoki, S. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.10.011 · Cited by 21
Liu, C., Dong, S., Xu, X., Yin, Y., Shriver, Z. H., Capila, I., Myette, J. R., & Venkataraman, G. (2010) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2010.07.044 · Cited by 21
St‐Amour, I., Laroche, A., Bazin, R., & Lemieux, R. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.06.005 · Cited by 21
Intravenous Immunoglobulin in the Management of Lupus Nephritis
Wenderfer, S. E., & Thacker, T. (2012) · Autoimmune Diseases · doi:10.1155/2012/589359 · Cited by 22
HACHULLA, E., Benvéniste, O., Hamidou, M. A., Mouthon, L., SCHLEINITZ, N., Lozeron, P., Léger, J., Vial, C., & Viala, K. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1204544 · Cited by 25
Solid‐Phase Enzymatic Remodeling Produces High Yields of Single Glycoform Antibodies
Tayi, V. S., & Butler, M. (2017) · Biotechnology Journal · doi:10.1002/biot.201700381 · Cited by 18
Structure and Dynamics of Immunoglobulin G Glycoproteins
Yagi, H., Yanaka, S., & Kato, K. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-2158-0_11 · Cited by 25
Issekutz, A. C., Rowter, D., Miescher, S., & Käsermann, F. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.05.003 · Cited by 22
Wu, Z., Li, H., Liu, D., Tao, L., Zhang, J., Liang, B., Liu, X., Wang, X., Li, X., Wang, Y., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5041346 · Cited by 22
Dojima, T., Nishina, T., Kato, T., Uno, T., Yagi, H., Kato, K., Ueda, H., & Park, E. Y. (2009) · Biotechnology Progress · doi:10.1002/btpr.313 · Cited by 21
Postól, E., Meyer, A., Cardillo, F., Alencar, R. D., Pessina, D. H., Nihei, J. S., Mariano, M., & Mengel, J. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02835.x · Cited by 21
Chang, J., Block, T. M., & Guo, J. (2014) · Antiviral Therapy · doi:10.3851/imp2907 · Cited by 23
The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange
Kuhne, F., Bonnington, L. S., Malik, S., Thomann, M., Avenal, C., Cymer, F., Wegele, H., Reusch, D., Mormann, M., & Bulau, P. (2019) · Antibodies · doi:10.3390/antib8040049 · Cited by 22
Maternal asthma is associated with persistent changes in allergic offspring antibody glycosylation
Sodemann, E. B., Dähling, S., Klopfleisch, R., Boiarina, E., Cataldo, D. D., Alhasan, M. M., Yildirim, A. Ö., Witzenrath, M., Tabeling, C., & Conrad, M. L. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13559 · Cited by 20
Variation of IgG N ‐linked glycosylation profile in diabetic retinopathy
Wu, Z., Pan, H., Liu, D., Zhou, D., Tao, L., Zhang, J., Wang, X., Li, X., Wang, Y., Wang, W., et al. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13160 · Cited by 21
Functional and structural modifications of influenza antibodies during pregnancy
Jennewein, M. F., Košíková, M., Noelette, F. J., Radvák, P., Boudreau, C. M., Campbell, J. D., Chen, W. H., Xie, H., Alter, G., & Pasetti, M. F. (2022) · iScience · doi:10.1016/j.isci.2022.104088 · Cited by 21
Modulation of Dendritic Cells and Regulatory T Cells by Naturally Occurring Antibodies
Kwekkeboom, J. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3461-0_10 · Cited by 20
Production of Highly Sialylated Monoclonal Antibodies
Raymond, C., Robotham, A., Kelly, J., Lattova, E., Perreault, H., & Durocher, Y. (2012) · Glycosylation · doi:10.5772/51301 · Cited by 20
“highlighted the implication of the Fc α2,6-sialylated fraction of IVIg in a murine model of rheumatoid arthritis [17].”
BackgroundThe antibody paradigm: present and future development as a scaffold for biopharmaceutical drugs
Jefferis, R. (2009) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-26-1 · Cited by 22
Heparin-induced thrombocytopenia: further evidence for a unique immune response
Pötschke, C., Selleng, S., Bröker, B. M., & Greinacher, A. (2012) · Blood · doi:10.1182/blood-2012-04-419424 · Cited by 21
RETRACTED: Dominant suppression of inflammation by glycan-hydrolyzed IgG
Nandakumar, K. S., Collin, M., Happonen, K. E., Croxford, A. M., Lundström, S. L., Zubarev, R. A., Rowley, M. J., Blom, A. M., & Holmdahl, R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301480110 · Cited by 20
RetractedIntravenous Immunoglobulin-Based Immunotherapy: an Arsenal of Possibilities for Patients and Science
Kotlán, B., Stroncek, D. F., & Marincola, F. M. (2009) · Immunotherapy · doi:10.2217/imt.09.67 · Cited by 20
Tong, X., Li, T., Orwenyo, J., Toonstra, C., & Wang, L. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.07.053 · Cited by 20
Kim, W., Kim, J., You, S., Do, J., Jang, Y., Kim, D., Lee, J., Ha, J., & Kim, H. H. (2019) · Analytical Biochemistry · doi:10.1016/j.ab.2019.02.012 · Cited by 20
Disruption of hepatocyte Sialylation drives a T cell-dependent pro-inflammatory immune tone
Oswald, D. M., Zhou, J. Y., Jones, M. B., & Cobb, B. A. (2020) · Glycoconjugate Journal · doi:10.1007/s10719-020-09918-y · Cited by 24
Woodall, D. W., Dillon, T. M., Kalenian, K., Padaki, R., Kuhns, S. T., Semin, D. J., & Bondarenko, P. V. (2022) · mAbs · doi:10.1080/19420862.2021.2004982 · Cited by 21
Unravelling Glycobiology by NMR Spectroscopy
Vitor, H. (2012) · InTech eBooks · doi:10.5772/48136 · Cited by 43
Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute
Prabagar, M. G., Choi, H., Park, J., Loh, S., & Kang, Y. (2013) · Clinical and Experimental Medicine · doi:10.1007/s10238-013-0255-4 · Cited by 21
Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans
Katoh, T., Katayama, T., Tomabechi, Y., Nishikawa, Y., Kumada, J., Matsuzaki, Y., & Yamamoto, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.737395 · Cited by 27
Understudied Factors Influencing Fc-Mediated Immune Responses against Viral Infections
Anand, S. P., & Finzi, A. (2019) · Vaccines · doi:10.3390/vaccines7030103 · Cited by 22
Petry, J., Rahmöller, J., Dühring, L., Lilienthal, G., Lehrian, S., Buhre, J. S., Bartsch, Y. C., Epp, A., Lunding, H. B., Moremen, K. W., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.056 · Cited by 19
Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune Diseases
Bordron, A., Morel, M., Bagacean, C., Dueymes, M., Pochard, P., Harduin‐Lepers, A., Jamin, C., & Pers, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073402 · Cited by 20
Tensor‐structured decomposition improves systems serology analysis
Tan, Z. C., Murphy, M., Alpay, H. S., Taylor, S. D., & Meyer, A. S. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110243 · Cited by 19
Liu, D., Dong, J., Zhang, J., Xu, X., Tian, Q., Meng, X., Wu, L., Zheng, D., Chu, X., Wang, W., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100080 · Cited by 21
Choi, H., Yang, S., Joo, J.-S., Park, M., Jin, Y., Kim, J., Lee, S.-Y., Lee, S.-V., Yun, T.-J., Cho, M., et al. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109215 · Cited by 19
Dalakas, M. C., Latov, N., & Kuitwaard, K. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2169134 · Cited by 19
Mao, C., Li, J., Feng, L., & Gao, W. (2023) · Antibody Therapeutics · doi:10.1093/abt/tbad004 · Cited by 29
The N-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation
Plavša, B., Szavits-Nossan, J., Blivajs, A., Rapčan, B., Radovani, B., Šesto, I., Štambuk, K., Mustapić, V., Đerek, L., Rudan, D., et al. (2023) · Biomolecules · doi:10.3390/biom13040605 · Cited by 19
Asthana, P., Vong, J. S. L., Kumar, G., Chang, R. C., Zhang, G., Sheikh, K. A., & Ma, C. H. E. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9430-9 · Cited by 21
Qian, H., Li, C., Zhang, Y., & Lin, Z. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.02.001 · Cited by 19
Deregulated Fcγ receptor expression in patients with CIDP
Quast, I., Cueni, F., Nimmerjahn, F., Tackenberg, B., & Lünemann, J. D. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000148 · Cited by 19
Self-citationAdvances in analytical methodologies to guide bioprocess engineering for bio-therapeutics
Saldova, R., Kilcoyne, M., Stöckmann, H., Millán‐Martín, S., Lewis, A. M., Tuite, C. M. E., Gerlach, J. Q., Berre, M. L., Borys, M., Li, Z. J., et al. (2016) · Methods · doi:10.1016/j.ymeth.2016.11.002 · Cited by 20
SHIP negatively regulates type II immune responses in mast cells and macrophages
Dobranowski, P., & Sly, L. M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0817-340r · Cited by 20
Washburn, N., Meccariello, R., Duffner, J. L., Getchell, K. M., Holte, K., Prod’homme, T., Srinivasan, K., Prenovitz, R., Lansing, J. C., Capila, I., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001142 · Cited by 24
Zhu, J., Ruan, Y., Fu, X. L., Zhang, L., Ge, G.-S., Wall, J. G., Zou, T., Yang, Z., Ding, N., & Hu, X. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00313 · Cited by 24
Ohyama, Y., Nakajima, K., Renfrow, M. B., Novák, J., & Takahashi, K. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1769479 · Cited by 23
Bhargava, R., Maeda, K., Tsokos, M., Pavlakis, M., Stillman, I. E., & Tsokos, G. C. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16140 · Cited by 19
Zhang, Q., Joubert, M. K., Polozova, A., Guzman, R. D., Lakamsani, K., Kinderman, F. S., Xiang, D., Shami, A. S. E., Miscalichi, N., Flynn, G. C., et al. (2020) · Biotechnology Progress · doi:10.1002/btpr.3045 · Cited by 21
Gillespie, E. R., & Ruitenberg, M. J. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6952 · Cited by 23
Expression Profiling and Glycan Engineering of IgG Subclass 1–4 in Nicotiana benthamiana
Kallolimath, S., Hackl, T., Gahn, R., Grünwald‐Gruber, C., Zich, W., Kogelmann, B., Lux, A., Nimmerjahn, F., & Steinkellner, H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00825 · Cited by 23
Self-citationShen, Y., Xiao, K., & Tian, Z. (2020) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.8952 · Cited by 19
Ye, P., Gu, B., Sun, Z., Li, Y., Zhang, Y., & Lu, H. (2021) · Chemical Communications · doi:10.1039/d1cc04142h · Cited by 19
Synthetic antibodies as therapeutics
Fuh, G. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.1.73 · Cited by 21
Ritamo, I., Cloutier, M., Valmu, L., Néron, S., & Räbinä, J. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.10.005 · Cited by 23
Treatment of inclusion body myositis: is low-dose intravenous immunoglobulin the solution?
Recher, M., Sahrbacher, U., Bremer, J., Arndt, B., Steiner, U. C., & Fontana, A. (2009) · Rheumatology International · doi:10.1007/s00296-009-1290-z · Cited by 19
Leontyev, D., Neschadim, A., & Branch, D. R. (2014) · Transfusion · doi:10.1111/trf.12680 · Cited by 21
Baudino, L., Nimmerjahn, F., Shinohara, Y., Furukawa, J., Petry, F., Verbeek, J. S., Nishimura, S., Ravetch, J. V., & Izui, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4107 · Cited by 19
Self-citationZhang, X., Huang, C., Jiang, Y., Shen, J., Geng, P., Zhang, W., & Huang, Q. (2016) · RSC Advances · doi:10.1039/c6ra23710j · Cited by 19
The analysis of the human plasma N-glycome in endometriosis patients
Berkes, E. A., Mužinić, A., Rigó, J. J., Tinneberg, H., & Oehmke, F. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.08.008 · Cited by 18
Autoantibodies in rheumatoid arthritis
Hoffmann, M. H., Lundberg, K., & Steiner, G. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00091-7 · Cited by 19
Identification and validation of IgG N-glycosylation biomarkers of esophageal carcinoma
Pan, H., Wu, Z., Zhang, H., Zhang, J., Liu, Y., Li, Z., Feng, W., Wang, G., Liu, Y., Zhao, D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.981861 · Cited by 17
IgG N‐ glycans are associated with prevalent and incident complications of type 2 diabetes
Memarian, E., Heijmans, R., Slieker, R. C., Sierra, A., Gornik, O., Beulens, J. W. J., Hanić, M., Elders, P. J. M., Pascual, J., Sijbrands, E. J. G., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3685 · Cited by 17
Jyonouchi, H. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1333717 · Cited by 22
The Case for Immunomodulatory Approaches in Treating HSV Encephalitis
Ramakrishna, C., Openshaw, H., & Cantin, E. M. (2013) · Future Virology · doi:10.2217/fvl.12.138 · Cited by 19
Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
Elovaara, I., & Hietaharju, A. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01317.x · Cited by 18
Malard-Castagnet, S., Dugast, E., Degauque, N., Pallier, A., Soulillou, J., Cesbron, A., Giral, M., Harb, J., & Brouard, S. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.10.021 · Cited by 18
Activating and inhibitory Fcγ receptors in immunotherapy: being the actor or being the target
Abès, R., Dutertre, C., Agnelli, L., & Teillaud, J. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.57 · Cited by 22
Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G
Fokkink, W. R., Falck, D., Santbergen, T. C. M., Huizinga, R., Wuhrer, M., & Jacobs, B. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139828 · Cited by 21
Kim, N. A., Jin, J. H., Kim, K., Lim, D. G., Cheong, H., Kim, Y. H., Ju, W., Kim, S. C., & Jeong, S. H. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0722-z · Cited by 18
Pabst, M., Benešová, I., Fagerer, S. R., Jacobsen, M., Eyer, K., Schmidt, G. W., Steinhoff, R., Krismer, J., Wahl, F., Preisler, J., et al. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00899 · Cited by 18
Chen, T. F., Sazinsky, S. L., Houde, D. J., DiLillo, D. J., Jaworski, J. A., Li, K. K., Cheng, G. T., Qiu, H., Engen, J. R., Ravetch, J. V., et al. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.07.001 · Cited by 19
Self-citationSaeui, C. T., Nairn, A. V., Galizzi, M., Douville, C. B., Gowda, P. C., Park, M., Dharmarha, V., Shah, S. R., Clarke, A., Austin, M. A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195812 · Cited by 22
Liu, T., Han, J., Zhang, R., Tang, Z., Yi, G., Gong, W., Wan, L., Hu, Q., Teng, J., Liu, H., et al. (2021) · Rheumatology · doi:10.1093/rheumatology/keab416 · Cited by 20
Monnet, C., Jacque, É., de Romeuf, C., Fontayne, A., Abache, T., Fournier, N., Dupont, G., Derache, D., Engrand, A., Bauduin, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.728322 · Cited by 17
Self-citationSvetlicky, N., Kivity, S., Odeh, Q., Shovman, O., Gertel, S., Amital, H., Gendelman, O., Volkov, A., Barshack, I., Bar‐Meir, E., et al. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12673 · Cited by 18
Amino Acids, Peptides, and Proteins
Hortin, G. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6164-9.00021-4 · Cited by 21
High‐dose intravenous immunoglobulins for the treatment of dermatological autoimmune diseases
Hoffmann, J. H. O., & Enk, A. (2017) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13389 · Cited by 18
Implementation of Glycan Remodeling to Plant-Made Therapeutic Antibodies
Bennett, L. D., Yang, Q., Berquist, B. R., Giddens, J. P., Ren, Z., Kommineni, V., Murray, R. C., White, E. L., Holtz, B. R., Wang, L., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020421 · Cited by 19
The emerging role of GlycoRNAs in immune regulation and recognition
Montag, N., Gousis, P., & Wittmann, J. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.107048 · Cited by 22
Myasthenia gravis: State of the art and new therapeutic strategies
Souto, E. B., Lima, B. J. D. A., Campos, J. R. S., Martins‐Gomes, C., Souto, S. B., & Silva, A. M. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577080 · Cited by 18
Liao, Z., Niu, Y., Wang, Z., Chen, J., Sun, X., Dong, L., & Wang, C. (2022) · Advanced Science · doi:10.1002/advs.202203236 · Cited by 18
Liu, P., Wang, X., Dun, A., Li, Y., Li, H., Wang, L., Zhang, Y., Li, C., Zhang, J., Zhang, X., et al. (2023) · Engineering · doi:10.1016/j.eng.2023.02.008 · Cited by 21
Štambuk, T., Kifer, D., Duvnjak, L. S., Lovrenčić, M. V., & Gornik, O. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284838 · Cited by 18
Current understanding and future directions
Jolles, S. R. A., Kaveri, S. V., & Orange, J. S. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04029.x · Cited by 17
Arsiwala, A., Bhatt, R., van Niekerk, L., Quintero-Cadena, P., Ao, X., Rosenbaum, A., Bhatt, A., Smith, A., Yang, Y., Anderson, K., et al. (2025) · mAbs · doi:10.1080/19420862.2025.2593055 · Cited by 16
Metadata
- Authors
- Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Kaneko, Yoshikatsu
- Nimmerjahn, Falk
- Ravetch, Jeffrey V.
- Venue
- Science
- Published
- 2006-08-04
- Volume
- 313
- Issue
- 5787
- Pages
- 670-673
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2035433348
- Cited by
- 1,754
- References
- 21
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 63 · 2023: 67 · 2022: 77 · 2021: 101 · 2020: 103 · 2019: 93 · 2018: 97 · 2017: 89 · 2016: 96 · 2015: 105 · 2014: 122 · 2013: 113 · 2012: 98
- FWCI
- 71.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IgG, Fc fragment, anti-inflammatory activity, Fc gamma receptor, immune complexes, intravenous immunoglobulin, antigen-specific immune response, innate immunity, adaptive immunity, pro-inflammatory effects
- MeSH terms
- Animals, Antibodies, Monoclonal, Arthritis, Arthritis, Rheumatoid, Glycosylation, Half-Life, Immunoglobulin G, Immunoglobulin Fc Fragments, Inflammation, Mice, Inbred C57BL, Nephritis, Polysaccharides, Receptors, Fc, Sialic Acids, Mice, Inbred NOD, Immunoglobulins, Intravenous, Receptors, IgG, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.